Replies to post #202869 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Eaglet's attempt to give Oxaydo abuse deterrent properties fell short.
FDA did not award ADF Labeling due to a sub par technology.
Elite has set the bar high for ADF labeling with their 2 bead tech.

[mrwrn2010]

Not according to the FDA.

[Couch]

That would be a HUGE no.

http://www.oxaydo.com

There is no evidence that OXAYDO® has reduced abuse liability compared to immediate-release oxycodone.

Nothing like spending millions to bring to market an "ADT" IR Oxy to have it no better than generic non ADT Oxy. Which one is doctors going to prescribe.